This page is for healthcare professionals.
It contains clinical study information written for dermatologists, pharmacists, nurses and other healthcare professionals.
For healthcare professionals
A non-steroidal cream, compared with 1% hydrocortisone.
Summary of a randomised, split-side, non-inferiority study of a 0.20% Centella asiatica extract nanogel cream in adults with eczema.
Design
| Population | Thirty adults aged 18 to 65 with bilateral eczematous lesions of comparable size (less than 10% difference) |
| Intervention | 0.20% w/w standardised Centella asiatica extract in a hyaluronic acid-grafted poly(N-isopropylacrylamide) nanogel cream, on one side |
| Comparator | 1% hydrocortisone cream on the contralateral side |
| Allocation | Randomised, split-side; each participant served as their own control |
| Duration | Six weeks; assessments at baseline and weeks 1, 2, 4 and 6 |
| Outcomes | Erythema index, skin hydration, transepidermal water loss, skin pH, Investigator’s Global Assessment, pruritus visual analogue scale, patient satisfaction, safety |
| Completers | Twenty-nine (72.4% female; mean age 40.5 ± 10.8 years) |
Results
| Erythema index | Both treatments significantly reduced erythema index at week 6. Non-inferiority to 1% hydrocortisone was demonstrated (95% CI of the difference, −0.469 to 0.095). |
| TEWL, hydration, pruritus | Early and sustained improvement from week 1 onward on both sides. Non-inferiority was demonstrated for all three. |
| Between-group difference | No significant difference at any time point. |
| IGA | Improvement increased over time on both sides, with earlier and higher proportions of more than 50% improvement on the Centella side. |
| Skin pH | Remained within the physiological range. |
| Tolerability | One mild, transient adverse event on the Centella side. Overall satisfaction was high on both sides. |
The formulation
The active is a standardised Centella asiatica extract containing more than 80% triterpenoid glycosides, with madecassoside and asiaticoside at a fixed ratio of 1.5 ± 0.5.
The carrier is a self-assembled nanogel of hyaluronic acid grafted with poly(N-isopropylacrylamide). In the published characterisation it increased the aqueous loading of asiatic acid 250 to 400 fold, with encapsulation efficiency above 86% and a transition at 34 to 35 °C.
The cream contains no corticosteroid and no added fragrance. The full ingredient list is on the Ingredients page.
Sources
- Efficacy of 0.20% Centella asiatica extract incorporated with hyaluronic acid-based nanosphere formulation compared with 1% hydrocortisone cream for eczema. European Academy of Dermatology and Venereology Congress 2026, e-Poster P0145.
- Self-assembled hyaluronic acid nanogel for asiatic acid. Polymers, 2021. doi.org/10.3390/polym13234071
- The extract as capsules in healthy volunteers, phase 1. Planta Medica, 2019. doi.org/10.1055/a-0835-6671
- A 0.05% gel of the extract after laser resurfacing, split-face, placebo-controlled. Journal of Alternative and Complementary Medicine, 2020. doi.org/10.1089/acm.2019.0325
Talk to us
If you would like the poster or a conversation with our scientific team, write to us and say you are a healthcare professional.